You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cholangitis

Showing 1 - 25 of 1,661
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Sclerosing Cholangitis Trial (Aramchol meglumine)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • Aramchol meglumine
  • (no location specified)
Oct 17, 2023

Acute Cholangitis Trial (ERCP)

Not yet recruiting
  • Acute Cholangitis
  • ERCP
  • (no location specified)
Jun 25, 2023

Primary Sclerosing Cholangitis (PSC) Trial in Warsaw (S-Adenosyl-L-methionine (SAMe), Placebo)

Recruiting
  • Primary Sclerosing Cholangitis (PSC)
  • S-Adenosyl-L-methionine (SAMe)
  • Placebo
  • Warsaw, Poland
    Department of Hepatology, Transplantology and Internal Medicine,
Sep 4, 2023

Primary Sclerosing Cholangitis Trial in Shanghai (CS0159 2mg, Placebo)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • CS0159 2mg
  • Placebo
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiao Tong University School of Medicine
Jun 7, 2023

Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)

Recruiting
  • Primary Sclerosing Cholangitis
  • Inflammatory Bowel Diseases
  • Stanford, California
    Stanford University
Jun 12, 2023

Primary Sclerosing Cholangitis Trial (BRS201, Placebo)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • (no location specified)
Apr 18, 2023

Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound

Not yet recruiting
  • Biliary Atresia
  • +2 more
  • Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
  • Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
  • (no location specified)
Jun 28, 2023

Program for Primary Biliary Cholangitis Lost in the System

Recruiting
  • Primary Biliary Cholangitis
    • Terrassa, Barcelona, Spain
      Hospital Universitari MútuaTerrassa
    Jun 16, 2023

    Primary Biliary Cholangitis (PBC) Trial in Shanghai (2mg CS0159, Placebo)

    Not yet recruiting
    • Primary Biliary Cholangitis (PBC)
    • 2mg CS0159
    • Placebo
    • Shanghai, Shanghai, China
      Renji Hospital, Shanghai Jiao Tong University School of Medicine
    Jun 7, 2023

    Primary Sclerosing Cholangitis, Liver and Intrahepatic Bile Duct Disorder, IBD Trial in Monza (Oral Vancomycin, Placebo)

    Recruiting
    • Primary Sclerosing Cholangitis
    • +2 more
    • Oral Vancomycin
    • Placebo
    • Monza, Monza E Brianza, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    May 16, 2023

    Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

    Not yet recruiting
    • Primary Biliary Cholangitis (PBC)
    • (no location specified)
    Aug 29, 2023

    Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Seladelpar 10 mg
    • Placebo
    • Lancaster, California
    • +4 more
    Sep 26, 2023

    Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)

    Recruiting
    • Primary Biliary Cholangitis
    • Fenofibrate 200mg
    • +2 more
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Mar 3, 2023

    Primary Sclerosing Cholangitis, Ulcerative Colitis, Biliary Tract Diseases Trial in Prague (Gluten-free diet)

    Recruiting
    • Primary Sclerosing Cholangitis
    • +4 more
    • Gluten-free diet
    • Prague, Czechia
      Institute of clinical and experimental medicine
    Sep 6, 2023

    Primary Sclerosing Cholangitis Trial in Paris, Monza, Barcelona (A3907)

    Recruiting
    • Primary Sclerosing Cholangitis
    • Paris, France
    • +2 more
    Jan 27, 2023

    Primary Sclerosing Cholangitis Trial in Seoul (HK-660S, Placebo)

    Active, not recruiting
    • Primary Sclerosing Cholangitis
    • Seoul, Korea, Republic of
    • +3 more
    May 10, 2023

    Genomics of Primary Sclerosing Cholangitis (PSC)

    Active, not recruiting
    • Primary Sclerosing Cholangitis (PSC)
    • Genetic Analysis
    • Rochester, Minnesota
      Mayo Clinic
    Jan 9, 2023

    Cholangitis Trial in Amsterdam (very short-course of standard of care antibiotics (24 hours), standard course of standard of

    Not yet recruiting
    • Cholangitis
    • very short-course of standard of care antibiotics (24 hours)
    • standard course of standard of care antibiotics (4 to 7 days)
    • Amsterdam, Noord Holland, Netherlands
      Amsterdam UMC
    Feb 28, 2023

    Cholangitis Trial

    Not yet recruiting
    • Cholangitis
      • (no location specified)
      Mar 23, 2023

      Primary Sclerosing Cholangitis Trial in Redwood City, Stanford (Hymecromone)

      Not yet recruiting
      • Primary Sclerosing Cholangitis
      • Redwood City, California
      • +1 more
      Nov 1, 2022

      Secondary Sclerosis Cholangitis Prospective

      Recruiting
      • Secondary Sclerosis Cholangitis in Critically Ill Patients
        • Graz, Austria
          Medical University Graz
        Sep 26, 2022

        Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

        Recruiting
        • Primary Biliary Cholangitis
        • Seladelpar 10 mg
        • Placebo
        • Chandler, Arizona
        • +3 more
        Oct 2, 2023

        Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,

        Completed
        • Nonalcoholic Steatohepatitis (NASH)
        • +2 more
        • Tel Aviv, Israel
          Tel Aviv Sourasky Medical Center
        Sep 7, 2023

        Primary Sclerosing Cholangitis Trial (Elafibranor 80 mg, Elafibranor 120 mg, Placebo Matched to Elafibranor 80 mg)

        Not yet recruiting
        • Primary Sclerosing Cholangitis
        • Elafibranor 80 mg
        • +3 more
        • (no location specified)
        Dec 27, 2022

        Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With

        Recruiting
        • Primary Biliary Cholangitis
        • Placebo Combined With Ursodeoxycholic Acid
        • Fenofibrate Combined With Ursodeoxycholic Acid
        • Xi'an, Shaanxi, China
          Ying han
        Mar 3, 2023